Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01675128 | ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Apr 25, 2016 | clinicaltrials |
| NCT02745639 | Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer(GRACE) | completed | Phase 2 | 18 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 0 | Apr 20, 2016 |
| NCT00022698 | Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer | completed | Phase 2 | 67 | Hoffmann-La RocheINDUSTRY | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01008475 | EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer(POSEIDON) | completed | Phase 1 / Phase 2 | 232 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 12 | Mar 30, 2016 | clinicaltrials |
| NCT02723253 | Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer | completed | Phase 2 | 18 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 0 | Mar 30, 2016 | clinicaltrials |
| NCT00813540 | The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors | completed | Phase 2 / Phase 3 | 52 | AHS Cancer Control AlbertaOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT01821105 | 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer | completed | Phase 2 | 21 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 2, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT00255229 | Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | completed | Phase 2 | 130 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01290926 | Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer(SoMore) | completed | Phase 2 | 97 | Jules Bordet InstituteOTHER | 1 | Feb 24, 2016 | clinicaltrials |
| NCT00332163 | Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy(STEPP) | completed | Phase 2 | 95 | AmgenINDUSTRY | 0 | Feb 23, 2016 | clinicaltrials |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00479752 | Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer(CORE 2) | completed | Phase 2 | 151 | Central European Cooperative Oncology GroupOTHER | 13 | Feb 18, 2016 | clinicaltrials |
| NCT00411450 | Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment(PRECEPT) | completed | Phase 2 | 116 | AmgenINDUSTRY | 0 | Feb 15, 2016 | clinicaltrials |
| NCT01074216 | Vitamin D Levels in Stage IV Colorectal Cancer Patients | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT00835185 | Study of IMC-11F8 in Participants With Colorectal Cancer | completed | Phase 2 | 44 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 29, 2016 | clinicaltrials |
| NCT00876954 | Preoperative Hyperthermia in Major Abdominal Surgery Patients | completed | Phase 1 / Phase 2 | 20 | Medical University of ViennaOTHER | 1 | Jan 21, 2016 | clinicaltrials |
| NCT01386242 | Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 108 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02489916 | Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 47 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02639403 | Palliative Short-Course Radiotherapy in Rectal Cancer | completed | Phase 2 | 18 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 0 | Dec 24, 2015 | clinicaltrials |
| NCT00550589 | Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus | completed | Phase 2 | 33 | AIDS Malignancy ConsortiumNETWORK | 1 | Dec 21, 2015 | clinicaltrials |
| NCT01022541 | Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer | completed | Phase 2 | 47 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01111838 | Clinical and Translational Study of STA-9090 | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00004547 | Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy | completed | Phase 2 | 188 | National Cancer Institute (NCI)NIH | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
| NCT01516489 | Improving Fecal Occult Blood Test Completion Rates Among Veterans | completed | Phase 1 / Phase 2 | 1,549 | Corporal Michael J. Crescenz VA Medical CenterFED | 1 | Oct 26, 2015 | clinicaltrials |
| NCT02575859 | Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients | completed | Phase 1 / Phase 2 | 20 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00103142 | Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | completed | Phase 2 | 74 | Michael Morse, MDOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00402961 | Trial of Acupuncture for Reduction of Post-Colectomy Ileus | completed | Phase 2 | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 17 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT01703910 | Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic | completed | Phase 2 | 29 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01333475 | MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01356264 | Multimodal Prehabilitation for Colorectal Surgery | completed | Phase 2 | 89 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00689624 | Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer | completed | Phase 2 | 30 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | completed | Phase 2 | 43 | Hoffmann-La RocheINDUSTRY | 1 | Aug 17, 2015 | clinicaltrials |
| NCT02518373 | Effect of G17DT in Patients With Stage II/III Colorectal Cancer(CC5) | completed | Phase 2 | 22 | Cancer Advances Inc.INDUSTRY | 0 | Aug 7, 2015 | clinicaltrials |
| NCT00100841 | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01161316 | Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours(MACRO-2) | completed | Phase 2 | 194 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00052507 | Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01853813 | First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer(CENTRAL) | completed | Phase 2 | 85 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT00890305 | Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone | completed | Phase 2 | 171 | Medivation, Inc.INDUSTRY | 6 | Jul 8, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT01461148 | Vaccination Against MSI Colorectal Cancer | completed | Phase 1 / Phase 2 | 22 | Oryx GmbH & Co. KGINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT00004195 | Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer | completed | Phase 2 | 28 | University of Alabama at BirminghamOTHER | 0 | Jun 15, 2015 | clinicaltrials |
| NCT01131078 | A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 306 | Hoffmann-La RocheINDUSTRY | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | completed | Phase 2 | 15 | SCRI Development Innovations, LLCOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01108107 | Neoadjuvant Treatment of Colon Cancer | completed | Phase 2 | 76 | Vejle HospitalOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01110941 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China(SCI-101) | completed | Phase 1 / Phase 2 | 20 | Shen LinOTHER | 1 | May 19, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Apr 25, 2016source: clinicaltrials